Chemical strucure of simvastatinSales, 2002-2004, as percentage of total during period.Sales, 2002-2004.
Find information on thousands of medical conditions and prescription drugs.

Zocor

Simvastatin is a hypolipidemic drug belonging to the class of pharmaceuticals called "statins". It is used to control hypercholesterolemia (elevated cholesterol levels) and to prevent cardiovascular disease. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Zafirlukast
Zagam
Zalcitabine
Zaleplon
Zanaflex
Zanamivir
Zantac
Zarontin
Zelnorm
Zerit
Zestoretic
Zestril
Zetia
Zevalin
Ziagen
Zidovudine
Zileuton
Ziprasidone
Zithromax
Zocor
Zofran
Zoladex
Zoledronic acid
Zolmitriptan
Zoloft
Zolpidem
Zometa
Zomig
Zonegran
Zonisamide
Zopiclone
Zosyn
Zovia
Zovirax
Zyban
Zymar
Zyprexa
Zyrtec
Zyvox

Simvastatin is a synthetic derivate of a fermentation product of Aspergillus terreus.

Uses

Simvastatin is a powerful lipid-lowering drug that can decrease low density lipoprotein (LDL) levels by up to 50%. It is used in doses of 10 mg up to 80 mg. Higher doses (160 mg) have been found to be too toxic, while giving only minimal benefit in terms of lipid lowering. There is no real effect on HDL and triglyceride levels.

From recent research it has become apparent that simvastatin and other statins inhibit the progression of atherosclerosis beyond their effects on LDL. A large number of explanations has been proposed, for example its inhibitory effect on macrophages in the atherosclerotic plaque lesions.

Rationing

Since its introduction, there has been a large debate surrounding the price for lipid-lowering treatment and its benefits on atherosclerosis. Although this has affected the other statins as well, simvastatin was the first statin drug to be used extensively in clinical practice.

A number of large epidemiological studies were conducted to discover which patients would benefit most from statin drugs; most studies involve simvastatin as the study drug. The most influential studies were the Scandinavian Simvastatin Survival Study (4S) and the Heart protection study (HPS).

It has now become apparent that patients with one or more risk factors for cardiovascular disease (such as diabetes mellitus, hypertension or a positive family history) can benefit from statins—even if they do not have substantially elevated cholesterol levels.

Simvastatin was introduced in the late 1980s, and in many countries it is now available as a generic preparation. This has led to a decrease of the price of most statin drugs, and a reappraisal of the health economics of preventive statin treatment.

In the UK, simvastatin (in a dose of 10mg) has recently become available to purchase from pharmacies without prescription.

Pharmacology

All statins act by inhibiting HMG-CoA reductase, the rate-limiting enzyme of the HMG-CoA reductase pathway, the metabolic pathway responsible for the endogenous production of cholesterol.

The drug is the form of an inactive lactone that is hydrolized after ingestion to produce the active agent. It is a white, nonhygroscopic, crystalline powder that is practically insoluble in water, and freely soluble in chloroform, methanol and ethanol.

Marketing

Reference: Drug Discovery Today editorial, 2005

Brand names: Zocor®, Zocor Heart Pro®, marketed by the pharmaceutical company Merck & Co. and Denan (Germany), Liponorm, Sinvacor, Sivastin (Italy), Lipovas (Japan), Lodales (France), Zocord (Austria and Sweden) and other.

Read more at Wikipedia.org


[List your site here Free!]


FDA approves new dosage range and indication for Zocor
From Drug Store News, 8/24/98

Merck received Food and Drug Administration approval to manufacture and market 80 mg tablets of Zocor, based on favorable lipid-lowering results from the Scandinavian Simvastatin Survival Study (4S). According to the study, patients who were treated with Zocor 80 mg at bedtime reduced their LDLs by 47 percent, whereas patients given 40 mg at bedtime decreased their LDL's by 41 percent. The 4S study also prompted a change in the official prescribing information for Zocor to recommend the 20 mg tablet as the usual starting dose. Patients needing only a moderate reduction of LDL cholesterol may still be started at 10 mg.

The incidence of myopathy was 0.7 percent for the 80 mg dosage and 0.2 percent for the 4- mg dosage. Incidence of liver enzyme elevations (sign of potential liver damage) was 2.1 percent for the 80 mg dosage and 0.9 percent for the 40 mg dosage. Patients taking the 80 mg dosage should be advised to receive and additional liver function test at three months.

In addition to pre-existing indications, Zocor has been approved by the FDA to be used as an adjunct to other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. The recommended dosage for patients with FD is 40 mg at bedtime or 80 mg per day in three divided doses of 20 mg, 20 mg and an evening dose of 40 mg.

COPYRIGHT 1998 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2004 Gale Group

Return to Zocor
Home Contact Resources Exchange Links ebay